Oxford BioMedica Company

25+ years enabling the world’s most progressive and successful viral vector therapies. Full service offering, supported by robust quality systems.

Founded Date: 1995
Last Funding Type: Grant
Headquarters: Oxford, Oxfordshire, United Kingdom
Investors Number: 1
Technology: Others
Employee Number: 51-100
Industry: Gene Therapy
Estimated Revenue: $10M to $50M
Number Of Exists: Grant
Funding Status: M&A
Investor Type: Company
Investment Stage: N/A
Total Funding: £12.3M